Loading...
OTCM
BDLSF
Market cap12mUSD
, Last price  
USD
Name

INOVIQ Ltd

Chart & performance

D1W1MN
OTCM:BDLSF chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
11.30%
Rev. 5Y
-19.41%
Div Yld LY
—
Div Yld TTM
—
Revenues
432k
-76.20%
05,718,00011,782182,8905,159275,678000044,02862,418520,798535,1011,271,000276,745398,193535,1181,815,313432,047
Net income
-8m
L+8.26%
-11,086,0003,161,0003,764,000-1,606,000-1,559,000-10,448,000-10,515,000-759,000-2,984,000-3,271,000-2,604,171-1,817,000-1,717,000-3,254,000-11,151,000-18,196,000-8,969,000-6,554,000-6,932,280-7,505,123
CFO
-6m
L+36.83%
-3,631,436-689,596-807,860-768,350-1,542,350-703,241-768,54299,375-126,654-78,116-2,378,313-1,965,267-1,570,719-2,536,577-5,260,377-6,061,160-7,024,574-4,322,924-4,662,673-6,380,063

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.

Key people

Leearne Hinch
Chief Executive Officer
Rebecca Lim
Chief Scientific Officer · since 2026
Emma Ball
Chief Commercial Officer · since 2025
Mark Edwards
Chief Financial Officer, Company Secretary · since 2022
Peter Gunzburg
Chairman of the Board · since 2025
Geoffrey Cumming
Non-Executive Director · since 2023
Mary Harney
Non-Executive Director · since 2024
Robert Johnston
Non-Executive Director · since 2019
Philip Powell
Non-Executive Director · since 2019
URL
https://www.inoviq.com/
IPO date
Apr 18, 1991
Employees
Domiciled in
AU
Incorporated in
AU
Legal address
'Tempo Building' Unit B1, 431 Roberts Road
SUBIACO, WA 6008
AU
Headquarters
PO Box 7493, Cloisters Square
Perth, WA 6850
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT